Biofidelity and CellCarta have announced a strategic partnership to utilise Biofidelity’s Aspyre® Lung in global clinical trials. Aspyre Lung simplifies the detection of non-small cell lung cancer ...

CAMBRIDGE, United Kingdom and MONTREAL, Jan. 9, 2025 /PRNewswire/ -- Biofidelity, a leader in innovative genomic solutions, and CellCarta, the global contract research organization (CRO ...

Designed to run on existing qPCR platforms, it integrates seamlessly into laboratories globally and aligns with CellCarta's mission to support global clinical trials through innovative genomic ...